TORVIB PLUS 10/50TORSEMIDE 10mg. IP + SPIRONOLACTONE 50mg. IP

Torvib Plus 10/50 tablets are used for fluid retention in heart failure, kidney or liver disease and for blood pressure control. Main uses: treatment of oedema (fluid retention) associated with heart failure; treatment of oedema associated with kidney disease; treatment of oedema associated with liver disease, including cirrhotic oedema; treatment of NYHA Class III-IV heart failure with reduced ejection fraction, to manage oedema and reduce hospitalisation for heart failure; as add-on therapy for hypertension, to lower blood pressure.

Common side effects of Torvib Plus 10/50 Tablet include increased frequency of urination; dizziness or light-headedness; headache; nausea, vomiting or stomach discomfort; diarrhoea or stomach cramps; leg cramps. Get medical help at once if you notice hyperkalaemia (high potassium in the blood); low blood pressure and worsening of kidney function, including acute kidney failure; ringing in the ears or hearing loss.

Each Torvib Plus 10/50 tablet contains Torsemide 10 mg + Spironolactone 50 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Torvib Plus 10/50 Tablet only as your doctor advises.

The MRP of Torvib Plus 10/50 Tablet is ₹107 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹81.52 and the PTS is ₹73.37.

Each Torvib Plus 10/50 tablet contains Torsemide 10 mg + Spironolactone 50 mg. It comes in a pack of 10x15 (Blister).

Inside each tablet, Torsemide is a loop diuretic. It works in the thick ascending part of the loop of Henle in the kidney, blocking the sodium-potassium-chloride carrier so that more sodium, chloride and water pass out in the urine. Spironolactone is an aldosterone antagonist. It acts in the distal renal tubule, where it makes the body lose sodium and water while holding on to potassium. Together the two actions increase urine output and help the body clear extra fluid, with spironolactone helping to balance the potassium loss caused by torsemide.

Must not be used by patients with known allergy to torsemide, spironolactone or povidone. Must not be used in patients who are anuric (passing no urine). Must not be used in patients with hepatic coma. Must not be used in patients with hyperkalaemia or Addison's disease, or together with eplerenone. Check with a doctor first if you have kidney or liver problems, are pregnant or breastfeeding, or are taking potassium supplements, potassium-containing salt substitutes or medicines that raise potassium.

Torvib Plus 10/50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.